Chia-Chin Lin

Chia-Chin Lin

Auto-generated profile, based on publicly available information

Chia-Chin Lin

School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1981 in The Lancet
Verified
Journal Article
Closed access
RBR.Palmer Beasley
R.Palmer Beasley
CLChia-Chin Lin
Chia-Chin Lin
LHLu-Yu Hwang
Lu-Yu Hwang
CCChia-Siang Chien
Chia-Siang Chien

1 August 1982 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
RBR. P. Beasley
R. P. Beasley
LHL.-Y. Hwang
L.-Y. Hwang
CLC.-C. Lin
C.-C. Lin
MLM.-L. Leu
M.-L. Leu
CSC. E. Stevens
C. E. Stevens
KCK.-P. Chen
K.-P. Chen
To determine the incidence of infections with hepatitis B virus (HBV) among Chinese preschool children, 1,510 children (mean age, 29 months) were tested for HBV markers; 15.9% were infected with HBV (7.8% positive for hepatitis B surface antigen [HBsAg] and 8.1% positive for antibody to HBsAg) and 84.1% were susceptible when the children were enrolled in the study. The average length of follow-up was 2.1 years among 1,110 children. Among the 924 susceptible children who were followed up, 10.6% had seroconversions for HBV markers, none of which was associated with clinical illness; the annual incidence of HBV infections was 5.0%. Among the 98 children who experienced HBV infections during the study, 23% became HBsAg carriers, and HBsAg persistence was age-related, with most carriers being among the youngest children infected. In contrast, among the children with HBV markers at the time of enrollment, 118 (49.2%) were HBsAg-positive and 86% were still positive on follow-up. The incidence of HBV infections was significantly associated with the frequency of previous injections.

1 March 1983 in Hepatology
Verified
Journal Article
Closed access
PDF file
PBPalmer R. Beasley
Palmer R. Beasley
LHLu-Yu Hwang
Lu-Yu Hwang
CSCladd E. Stevens
Cladd E. Stevens
CLChia-Chin Lin
Chia-Chin Lin
FHFon-Jou Hsieh
Fon-Jou Hsieh
WSWolf Szmuness
Wolf Szmuness

1 August 1981 in The Lancet
Verified
Journal Article
Closed access
RBR. Palmer Beasley
R. Palmer Beasley
CLChia-Chin Lin
Chia-Chin Lin
KWKwei-Yu Wang
Kwei-Yu Wang
FHFon-Jou Hsieh
Fon-Jou Hsieh
LHLu-Yu Hwang
Lu-Yu Hwang
WSWolf Szmuness
Wolf Szmuness

9 December 2014 in British Journal of Cancer
Verified
Journal Article
Open access
HCH-M Chen
H-M Chen
CTC-M Tsai
C-M Tsai
YWY-C Wu
Y-C Wu
KLK-C Lin
K-C Lin
CLC-C Lin
C-C Lin
Although exercise has been addressed as an adjuvant treatment for anxiety, depression and cancer-related symptoms, limited studies have evaluated the effectiveness of exercise in patients with lung cancer. We recruited 116 patients from a medical centre in northern Taiwan, and randomly assigned them to either a walking-exercise group (n=58) or a usual-care group (n=58). We conducted a 12-week exercise programme that comprised home-based, moderate-intensity walking for 40 min per day, 3 days per week, and weekly exercise counselling. The outcome measures included the Hospital Anxiety and Depression Scale and the Taiwanese version of the MD Anderson Symptom Inventory. We analysed the effects of the exercise programme on anxiety, depression and cancer-related symptoms by using a generalised estimating equation method. The exercise group patients exhibited significant improvements in their anxiety levels over time (P=0.009 and 0.006 in the third and sixth months, respectively) and depression (P=0.00006 and 0.004 in the third and sixth months, respectively) than did the usual-care group patients. The home-based walking exercise programme is a feasible and effective intervention method for managing anxiety and depression in lung cancer survivors and can be considered as an essential component of lung cancer rehabilitation.

24 January 2013 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
THTsai-Wei Huang
Tsai-Wei Huang
STSung-Hui Tseng
Sung-Hui Tseng
CLChia-Chin Lin
Chia-Chin Lin
CBChyi-Huey Bai
Chyi-Huey Bai
CCChing-Shyang Chen
Ching-Shyang Chen
KTKa-Wai Tam
Ka-Wai Tam
Background: Lymphedema is a common complication of axillary dissection for breast cancer. We investigated whether manual lymphatic drainage (MLD) could prevent or manage limb edema in women after breast-cancer surgery. Methods: We performed a systematic review and meta-analysis of published randomized controlled trials (RCTs) to evaluate the effectiveness of MLD in the prevention and treatment of breast-cancer-related lymphedema. The PubMed, EMBASE, CINAHL, Physiotherapy Evidence Database (PEDro), SCOPUS, and Cochrane Central Register of Controlled Trials electronic databases were searched for articles on MLD published before December 2012, with no language restrictions. The primary outcome for prevention was the incidence of postoperative lymphedema. The outcome for management of lymphedema was a reduction in edema volume. Results: In total, 10 RCTs with 566 patients were identified. Two studies evaluating the preventive outcome of MLD found no significant difference in the incidence of lymphedema between the MLD and standard treatment groups, with a risk ratio of 0.63 and a 95% confidence interval (CI) of 0.14 to 2.82. Seven studies assessed the reduction in arm volume, and found no significant difference between the MLD and standard treatment groups, with a weighted mean difference of 75.12 (95% CI, −9.34 to 159.58). Conclusions: The current evidence from RCTs does not support the use of MLD in preventing or treating lymphedema. However, clinical and statistical inconsistencies between the various studies confounded our evaluation of the effect of MLD on breast-cancer-related lymphedema.